Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.4675
+0.0266 (6.03%)
At close: Oct 9, 2026, 4:00 PM EDT
0.463252
-0.0042 (-0.91%)
After-hours: Oct 9, 2026, 7:55 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $15.62 million as of October 9, 2026. It is the 38,865th most valuable company in the world and the 5,386th biggest in the United States. Its market cap has increased by 155.80% in one year.
Market Cap
15.62M
Enterprise Value
-30.04M
1-Year Change
155.80%
Global Rank
Country Rank
#5,386 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $15.62M, a decrease of -76.07%. That is a compound annual growth rate of -24.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 15.62M | -47.56% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 16.04M |
| Marker Therapeutics | 16.01M |
| Kiora Pharmaceuticals | 16.00M |
| Radiopharm Theranostics | 15.63M |
| Actuate Therapeutics | 15.61M |
| TScan Therapeutics | 15.60M |
| SeaStar Medical Holding | 15.38M |
| Lipocine | 15.33M |